Oct
2026
Fiera Milano, Italy
Visit us
stand 16A6, Finished Dosage & Formulation

Blau Farmaceutica S.A

Exhibitor at CPHI Milan 2026
About Us

Blau is a leading pharmaceutical company in the institutional segment of the market where it operates, as well as a biotechnology pioneer among Brazilian companies, with its own portfolio of high-complexity drugs with a focus on its segments of operation in the industry, such as immunology, hematology, oncology, nephrology, infectious diseases, anesthesiology, and others.

It has a continental footprint and is present in seven South American countries – Argentina, Brazil, Chile, Colombia, Ecuador, Peru and Uruguay – and in the USA. 

  • Country/Region:
    Brazil
  • On CPHI since:
    2015
  • Certificates:
    2
  • Employees:
    1000 - 4999
Company types
Biopharmaceutical company
Primary activities
Biopharmaceutical
Contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 16A6, Finished Dosage & Formulation

Products Featured at CPHI Milan 2026

  • Emicizumab

    Product Emicizumab

    Emicizumab Biosimilar
  • Nivolumab Biosimilar

    Product Nivolumab Biosimilar

    Nivolumab Biosimilar
  • Pegfilgrastim

    Product Pegfilgrastim

    PegFilgrastim biosimilar
  • Aciclovir

    Product Aciclovir

    BLAU FARMACÊUTICA S/A offers a wide range of products which includes aciclovir. Features: it is antivirals and antiretrovirals. Contact us for more information.
  • Alfaepoetin -Rhu    

    Product Alfaepoetin -Rhu    

    BLAU FARMACÊUTICA S/A offers a wide range of products which includes alfaepoetin -rhu. Contact us for more information.

Blau Farmaceutical S.A Resources (1)